MohanaSundaram A, Kesavan G, Nagaraj K, Ramesh P. Donanemab for Alzheimer’s disease: a translational milestone or just another chapter in the anti-amyloid antibody story?. Am J Transl Med [Internet]. 2025 Sep. 1 [cited 2026 Jun. 27];9(3):104-9. Available from: https://ajtm.journals.publicknowledgeproject.org/index.php/ajtm/article/view/3649